+ All Categories
Home > Documents > Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative...

Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative...

Date post: 18-Jan-2016
Category:
Upload: daniela-polly-thompson
View: 220 times
Download: 0 times
Share this document with a friend
Popular Tags:
19
Laboratory Diagnosis of Cancer 1. Histological methods 2. Cytopathology - FNAC/Exfoliative 3. Immunohistochemistry/ EM 4. Molecular diagnosis 5. Tumor Markers
Transcript
Page 1: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Laboratory Diagnosis of Cancer

1. Histological methods

2. Cytopathology - FNAC/Exfoliative

3. Immunohistochemistry/ EM

4. Molecular diagnosis

5. Tumor Markers

Page 2: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Histological methods - Frozen

SectionUsed per-operatively

• To determine nature of mass lesion - whether inflammatory / benign / malignant• To evaluate sentinel node status, margins of excised cancer

Page 3: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Cytological Methods - Fine Needle Aspiration Cytology

• Using regular small bore needle : readily palpable sites – breast, lymph node, thyroid

• Using special needle: prostate• Using ultrasound/CT guidance: deep seated

structures also

Page 4: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Cytological Methods - Exfoliative

Cytology

• Pap smears : Carcinoma cervix

• Ascitic / pleural fluid cytology

• Cerebrospinal fluid

Page 5: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Immunohistochemistry

• Categorizing undifferentiated malignancies

• Categorizing leukemia / lymphomas

• Determining site of origin of metastasis

• Detecting molecules of prognostic / therapeutic significance

Page 6: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Immunohistochemical stains Carcinomas: Cytokeratin, EMA, CEA

Sarcomas: Vimentin Muscle derived sarcomas: Desmin, Actin Tumors of endothelium: Factor VIII, CD31

Leukocyte malignancies1. CD 45: LCA (Leukocyte common antigen) - almost all except mature RBCs2. CD 19, 20: B Cell Lymphoma3. CD 3, 5, 7, 4, 8: T cell Lymphoma4. CD 15+, CD30+ : Hodgkin’s Lymphoma

Neural crest derived tumors: S100 +ve 1. Neuroendocrine tumors(carcinoid) : S 100 & Chromogranin 2. Neural tumors (neuroblastoma) : S-100 & NF +ve 3. Melanoma : S-100 & HMB45 +ve 4. Small cell carcinoma : S100 & NSE

Miscellaneous: Mesothelioma: Calretinin, Medullary carcinoma of thyroid: Calcitonin, Myeloma: kappa/lambda light chains, Prostate carcinoma: PSA, Hepatocellular carcinoma: AFP, Trophoblastic tumors: HCG, Gastrointestinal stromal tumors: CD117 (c-Kit), Mantle cell lymphoma: Cyclin D1

Page 7: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

7CD 19

1. Lymphoma

2. Neuroblastoma

3. Rhabdomyosarcoma

4. Melanoma

Page 8: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

A 49-year-old man complains of pain in his left thigh for 3 months. On physical examination his thigh is increased in size, compared to the right. A plain film radiograph reveals the presence of a 15 cm solid mass that does not appear to arise from bone, but it does have infiltrative margins. A biopsy of this mass is taken, and on microscopic examination the mass is composed of highly pleomorphic spindle cells. Which of the following immunohistochemical markers is most likely to be demonstrated in the cells of this mass?

A Cytokeratin B Factor VIII C Alpha fetoprotein D Lambda light chain E Vimentin

Page 9: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

9

S100

If also positive for

1. NF - ?

2. Chromogranin - ?

3. HMB45 - ?

Page 10: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Molecular diagnosis

• Cytogenetic analysis• PCR assays ( polymerase chain reaction)• FISH ( fluorescent in-situ hybridisation)• Tissue arrays

Useful in diagnosis, prognosis Minimal residual disease, To detect hereditary predisposition to cancer

Page 11: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Flow Cytometry

• Rapid quantitative analysis of cell features like membrane antigens, DNA content

• Identification of cell surface antigens in leukemias/lymphomas

• Ploidy analysis in solid tumours

Page 12: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

TUMOR MARKER ASSOCIATED CANCER

AFP Hepatocellular carcinoma, yolk sac tumor (endodermal sinus tumor) of ovary or testis

Bence Jones protein

Multiple myeloma, Waldenström's macroglobulinemia (represent light chains in urine)

CA 15-3 Breast carcinoma

CA 19-9 Pancreatic, colorectal carcinomas

CA 125 Surface-derived ovarian cancer (e.g., serous cystadenocarcinoma; helpful in distinguishing benign from malignant tumors)

CEA Colorectal and pancreatic carcinomas (monitor for recurrences)

LDH Malignant lymphoma (prognostic factor for response to standard therapy)

PSA Prostate carcinoma (also increased in prostate hyperplasia)

Page 13: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

CEA (Carcinoembryonic Antigen)

• Glycoprotein, produced by embryonic tissue of gut/pancreas/liver

• Increased in Cancer of Colon, Pancreas, Breast • Also increased in benign disorders – alcoholic cirrhosis,

hepatitis, ulcerative colitis• Useful in postoperative detection of residual disease /

recurrence of colon cancer, monitoring treatment of breast cancer

Page 14: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

AFP (Alpha Feto-Protein)

• Glycoprotein, produced by yolk sac/fetal liver/GIT• Increased in Cancer of liver / germ cell tumors of testes• Also increased in benign disorders – alcoholic cirrhosis,

hepatitis, toxic liver injury, pregnancy• Useful in post-therapy measurement – index of response

to therapy / recurrence

Page 15: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Electron microscopy in cancer• Carcinomas: Tonofilaments, desmosomes• Neuroendocrine tumors: Secretory granules• Malignant melanoma: Melanosomes• Langerhan cell histiocytosis: Birbeck granules• Insulinoma: Crystal containing granules

Page 16: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.
Page 17: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.
Page 18: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.
Page 19: Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.

Required reading: Robbins Basic Pathology 9E, p207-213

Recommended reading: Robbins and Cotran Pathologic Basis of Disease 8E, p323-327


Recommended